Table 1.

The relationship between prognostic-related mitochondrial genes and clinicopathologic parameters.

Gene		Gender (male/female)	Grade (G1–2/G3–4)	Stage (I–II/III–IV)	T stage (T1–T2/T3–T4)	N stage (N0/NI–X)	M stage (M0/MI–X)
N		353/186	249/282	331/205	349/190	241/298	428/109
ACAD11	t value	3.637	2.16	2.979	2.359	0.149	NA∗
	P value	<0.001	0.031	0.003	0.019	0.881	<0.001
ACADSB	t value	1.475	NA∗	NA∗	6.841	0.135	4.957
	P value	0.141	<0.001	<0.001	<0.001	0.893	<0.001
BID	t value	2.926	NA∗	6.911	6.304	0.558	3.497
	P value	0.004	<0.001	<0.001	<0.001	0.577	0.001
PYCR1	t value	3.342	NA∗	NA∗	5.099	0.032	3.09
	P value	0.001	<0.001	<0.001	<0.001	0.974	0.002
SLC25A27	t value	1.392	3.023	NA∗	NA∗	0.749	0.193
	P value	0.165	0.003	0.009	0.037	0.455	0.847
STAR	t value	0.655	NA∗	4.251	4.485	0.491	3.346
	P value	0.513	0.007	<0.001	<0.001	0.624	0.001

NA: not available; ^∗nonparametric Mann–Whitney rank sum test. (The statistical method was t-test or nonparametric Mann–Whitney rank sum test with only one test. The reported P value was the fdr value).